Study type

Study topic

Other

Study topic, other

Disease/Epidemiology study, A pilot on rapid data analytics (referred to in this report as RDA) coordinated by the European Medicines Agency (EMA)

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Drug utilisation

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cohort
Case-control
Population studied

Short description of the study population

NA

Age groups

Preterm newborn infants (0 – 27 days)
Term newborn infants (0 – 27 days)
Infants and toddlers (28 days – 23 months)
Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

100000
Study design details

Main study objective

A pilot on rapid data analytics coordinated by the EMA was performed with the PRAC from November 2019 to January 2021. Its aim was to test the feasibility and usefulness of a process for rapid identification, analysis and reporting of results of epidemiological questions that may arise in in the context of regulatory assessments.

Data analysis plan

Please refer to the executive summary
Documents
Study results
English (110.89 KB - PDF)View document